Endo International Ordinary Shares reported $472.5M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Aerie Pharmaceuticals AERI:US $ 29.57M 6.52M
Amarin AMRN:US $ 58.63M 13.76M
Bristol Myers Squibb BMY:US $ 9210M 33M
Eli Lilly And LLY:US $ 5057.5M 680.4M
Hikma Pharmaceutical HIK:LN 623M 62M
Horizon Pharma HZNP:US $ 646.2M 23.99M
JAZZ PHA JAZZ:US $ 808.67M 110.23M
Lannett LCI:US $ 3.08M 2.63M
Merk MRK:US $ 10895M 328M
Novartis NOVN:VX 9.34B 277M
Pacira Pharmaceuticals PCRX:US $ 118.78M 3.13M
Perrigo Ordinary Shares PRGO:US $ 372.1M 34.3M
Pfizer PFE:US $ 19071M 3420M
Phibro Animal Health PAHC:US $ 71.63M 0.95M
Revance Therapeutics RVNC:US $ 18.84M 1.48M
Supernus Pharmaceuticals SUPN:US $ 149.59M 15.02M
Takeda 4502:JP Y 679583M 114674M
Teva Pharmaceutical TEVA:IT 1.83B 26M
Xeris Pharmaceuticals Inc XERS:US $ 20.5M 4.7M
Zoetis ZTS:US $ 1432M 11M